GLAND — Gland Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Gland Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13,252	30,058	32,427	37,628	18,394
Net Total Accounts Receivable
Net Total Receivables	6,647	7,479	12,928	10,360	18,106
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28,463	51,236	58,521	69,008	56,452
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11,566	12,920	16,804	17,361	38,302
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	40,860	64,961	78,336	87,775	106,612
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,590	5,125	5,820	7,291	13,984
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	4,398	5,928	6,760	8,188	19,374
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	36,462	59,032	71,576	79,587	87,238
Total Liabilities & Shareholders' Equity	40,860	64,961	78,336	87,775	106,612
Total Common Shares Outstanding